Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
136.70
+2.31 (1.72%)
At close: Mar 9, 2026, 4:00 PM EDT
136.70
0.00 (0.00%)
After-hours: Mar 9, 2026, 5:00 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $1.84 billion as of March 9, 2026. Its market cap has increased by 761.50% in one year.
Market Cap
1.84B
Enterprise Value
1.79B
1-Year Change
761.50%
Ranking
Category
Stock Price
$136.70
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $1.84B, an increase of 1,175.80%. That is a compound annual growth rate of 707.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.81B | 45.75% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 1.93B |
| Mesoblast | 1.91B |
| Aurinia Pharmaceuticals | 1.90B |
| Nanobiotix | 1.88B |
| Sarepta Therapeutics | 1.85B |
| Recursion Pharmaceuticals | 1.85B |
| Tyra Biosciences | 1.84B |
| Definium Therapeutics | 1.84B |